Combined use of AB‐132 (Meturedepa, Turloc) and X irradiation in the management of advanced bronchogenic carcinoma

[1]  J. Sokal,et al.  Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias. , 1962, Cancer chemotherapy reports.

[2]  T. Bardos.  Consideration of chemical reaction mechanisms in relationship to the biological action of "dual antagonists". , 1962, Biochemical pharmacology.

[3]  Ross Ca,et al.  Clinical experience with AB-132. , 1962 .

[4]  Hall Be,et al.  Treatment of far-advanced cancer with 5-fluorouracil, used alone and in combination with irradiation. Incidence and duration of remission and survival-time data in 223 patients. , 1962 .

[5]  J. Holland,et al.  Combined radiation-chemotherapy for bronchogenic carcinoma--pilot study. , 1962, Cancer chemotherapy reports.

[6]  E. Mirand,et al.  Effect of Chemotherapeutic Agents on Friend Virus-Induced Leukemia in Mice.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[7]  Allaire Fj,et al.  Cancer chemotherapy with 5-fluorouracil alone and in combination with x-ray therapy. , 1961 .

[8]  L. Sensenbrenner,et al.  One year's clinical experience with 5-fluorouracil and x-ray-a preliminary report. , 1961, Cancer chemotherapy reports.

[9]  M. Kligerman.  The role of combination radiation and chemotherapy , 1960 .

[10]  F. Willett,et al.  The potentiation of radiation effects with 5-fluorouracil. , 1960, Cancer chemotherapy reports.

[11]  A. Segaloff,et al.  ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents , 1959, Nature.

[12]  G. Tarnowski,et al.  Combination therapy of malignant tumors with ionizing radiations and chemicals; a review. , 1957, Cancer research.